Investigating the role of group II introns and reverse transcriptases in RNA diagnostics
Group II Intron and Related Reverse Transcriptases
This study is looking at certain molecules that help with RNA processing to find better ways to detect cancer using simple blood tests, so patients can get more accurate and less invasive diagnoses.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-11090149 on NIH RePORTER |
What this research studies
This research focuses on understanding group II introns and their related reverse transcriptases, which are important for RNA processing and diagnostics. The team will analyze clinical samples using advanced RNA sequencing techniques to identify cancer biomarkers and improve liquid biopsy methods. By studying the biochemical mechanisms and biological functions of these molecules, the research aims to enhance diagnostic capabilities for various cancers. Patients may benefit from improved methods for detecting cancer through non-invasive tests.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals undergoing evaluation for cancer who may benefit from advanced RNA diagnostic techniques.
Not a fit: Patients with conditions unrelated to cancer or those not undergoing diagnostic evaluations may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and less invasive cancer diagnostics for patients.
How similar studies have performed: Previous research has shown promise in using RNA sequencing for cancer diagnostics, indicating that this approach could be effective.
Where this research is happening
Austin, United States
- University of Texas at Austin — Austin, United States (Active)
Researchers
- Principal investigator: Lambowitz, Alan M. — University of Texas at Austin
- Study coordinator: Lambowitz, Alan M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.